Methotrexate therapy for ectopic pregnancy in adolescents

M. L. McCord, D. Muram, G. H. Lipscomb, M. P. Powell, Kristopher Arheart

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Study Objective: To determine the suitability and efficacy of methotrexate (MTX) therapy for adolescent patients with ectopic pregnancy. Materials: Patients with ectopic pregnancy were treated with methotrexate, 50 mg/m2 intramuscularly. Follow-up determinations of quantitative βhCG levels were done on days 1, 4, and 7. They were then seen weekly until βhCG levels were less than 15 mIU/ml. Participants: Adolescents with ectopic pregnancy (55 patients) received MTX therapy and comprised the study group. They were compared with 186 adults similarly treated. The groups were compared for treatment outcome and for compliance with the rigid protocol requirements. Main outcome measures: Treatment success was defined as a patient who required no surgical intervention and whose βhCG levels declined to < 15 mIU/ml. Results: 85% of patients required no surgical intervention following MTX injection. Surgical intervention rates were slightly higher and success rates slightly lower for adolescent patients, but these differences were not statistically significant (p = .71). Although adult patients were more likely to have a perfect compliance rating, comparison of all compliance categories showed no significant differences p = .17). Conclusions: MTX therapy is satisfactory for adolescent patients. It is effective, and adolescent patients are able to comply with the requirements of a rigid protocol.

Original languageEnglish
Pages (from-to)71-73
Number of pages3
JournalJournal of Pediatric and Adolescent Gynecology
Volume9
Issue number2
StatePublished - Sep 17 1997
Externally publishedYes

Fingerprint

Ectopic Pregnancy
Methotrexate
Therapeutics
Compliance
Outcome Assessment (Health Care)
Injections

Keywords

  • Ectopic pregnancy
  • Methotrexate compliance
  • Pregnancy in adolescents

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

McCord, M. L., Muram, D., Lipscomb, G. H., Powell, M. P., & Arheart, K. (1997). Methotrexate therapy for ectopic pregnancy in adolescents. Journal of Pediatric and Adolescent Gynecology, 9(2), 71-73.

Methotrexate therapy for ectopic pregnancy in adolescents. / McCord, M. L.; Muram, D.; Lipscomb, G. H.; Powell, M. P.; Arheart, Kristopher.

In: Journal of Pediatric and Adolescent Gynecology, Vol. 9, No. 2, 17.09.1997, p. 71-73.

Research output: Contribution to journalArticle

McCord, ML, Muram, D, Lipscomb, GH, Powell, MP & Arheart, K 1997, 'Methotrexate therapy for ectopic pregnancy in adolescents', Journal of Pediatric and Adolescent Gynecology, vol. 9, no. 2, pp. 71-73.
McCord ML, Muram D, Lipscomb GH, Powell MP, Arheart K. Methotrexate therapy for ectopic pregnancy in adolescents. Journal of Pediatric and Adolescent Gynecology. 1997 Sep 17;9(2):71-73.
McCord, M. L. ; Muram, D. ; Lipscomb, G. H. ; Powell, M. P. ; Arheart, Kristopher. / Methotrexate therapy for ectopic pregnancy in adolescents. In: Journal of Pediatric and Adolescent Gynecology. 1997 ; Vol. 9, No. 2. pp. 71-73.
@article{798c7a85da93430ba2fb1d29f8f201a4,
title = "Methotrexate therapy for ectopic pregnancy in adolescents",
abstract = "Study Objective: To determine the suitability and efficacy of methotrexate (MTX) therapy for adolescent patients with ectopic pregnancy. Materials: Patients with ectopic pregnancy were treated with methotrexate, 50 mg/m2 intramuscularly. Follow-up determinations of quantitative βhCG levels were done on days 1, 4, and 7. They were then seen weekly until βhCG levels were less than 15 mIU/ml. Participants: Adolescents with ectopic pregnancy (55 patients) received MTX therapy and comprised the study group. They were compared with 186 adults similarly treated. The groups were compared for treatment outcome and for compliance with the rigid protocol requirements. Main outcome measures: Treatment success was defined as a patient who required no surgical intervention and whose βhCG levels declined to < 15 mIU/ml. Results: 85{\%} of patients required no surgical intervention following MTX injection. Surgical intervention rates were slightly higher and success rates slightly lower for adolescent patients, but these differences were not statistically significant (p = .71). Although adult patients were more likely to have a perfect compliance rating, comparison of all compliance categories showed no significant differences p = .17). Conclusions: MTX therapy is satisfactory for adolescent patients. It is effective, and adolescent patients are able to comply with the requirements of a rigid protocol.",
keywords = "Ectopic pregnancy, Methotrexate compliance, Pregnancy in adolescents",
author = "McCord, {M. L.} and D. Muram and Lipscomb, {G. H.} and Powell, {M. P.} and Kristopher Arheart",
year = "1997",
month = "9",
day = "17",
language = "English",
volume = "9",
pages = "71--73",
journal = "Journal of Pediatric and Adolescent Gynecology",
issn = "1083-3188",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Methotrexate therapy for ectopic pregnancy in adolescents

AU - McCord, M. L.

AU - Muram, D.

AU - Lipscomb, G. H.

AU - Powell, M. P.

AU - Arheart, Kristopher

PY - 1997/9/17

Y1 - 1997/9/17

N2 - Study Objective: To determine the suitability and efficacy of methotrexate (MTX) therapy for adolescent patients with ectopic pregnancy. Materials: Patients with ectopic pregnancy were treated with methotrexate, 50 mg/m2 intramuscularly. Follow-up determinations of quantitative βhCG levels were done on days 1, 4, and 7. They were then seen weekly until βhCG levels were less than 15 mIU/ml. Participants: Adolescents with ectopic pregnancy (55 patients) received MTX therapy and comprised the study group. They were compared with 186 adults similarly treated. The groups were compared for treatment outcome and for compliance with the rigid protocol requirements. Main outcome measures: Treatment success was defined as a patient who required no surgical intervention and whose βhCG levels declined to < 15 mIU/ml. Results: 85% of patients required no surgical intervention following MTX injection. Surgical intervention rates were slightly higher and success rates slightly lower for adolescent patients, but these differences were not statistically significant (p = .71). Although adult patients were more likely to have a perfect compliance rating, comparison of all compliance categories showed no significant differences p = .17). Conclusions: MTX therapy is satisfactory for adolescent patients. It is effective, and adolescent patients are able to comply with the requirements of a rigid protocol.

AB - Study Objective: To determine the suitability and efficacy of methotrexate (MTX) therapy for adolescent patients with ectopic pregnancy. Materials: Patients with ectopic pregnancy were treated with methotrexate, 50 mg/m2 intramuscularly. Follow-up determinations of quantitative βhCG levels were done on days 1, 4, and 7. They were then seen weekly until βhCG levels were less than 15 mIU/ml. Participants: Adolescents with ectopic pregnancy (55 patients) received MTX therapy and comprised the study group. They were compared with 186 adults similarly treated. The groups were compared for treatment outcome and for compliance with the rigid protocol requirements. Main outcome measures: Treatment success was defined as a patient who required no surgical intervention and whose βhCG levels declined to < 15 mIU/ml. Results: 85% of patients required no surgical intervention following MTX injection. Surgical intervention rates were slightly higher and success rates slightly lower for adolescent patients, but these differences were not statistically significant (p = .71). Although adult patients were more likely to have a perfect compliance rating, comparison of all compliance categories showed no significant differences p = .17). Conclusions: MTX therapy is satisfactory for adolescent patients. It is effective, and adolescent patients are able to comply with the requirements of a rigid protocol.

KW - Ectopic pregnancy

KW - Methotrexate compliance

KW - Pregnancy in adolescents

UR - http://www.scopus.com/inward/record.url?scp=0030758460&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030758460&partnerID=8YFLogxK

M3 - Article

C2 - 8795780

AN - SCOPUS:0030758460

VL - 9

SP - 71

EP - 73

JO - Journal of Pediatric and Adolescent Gynecology

JF - Journal of Pediatric and Adolescent Gynecology

SN - 1083-3188

IS - 2

ER -